Literature DB >> 15100234

Uptake and rapid transfer of fluorescent ceramide analogues to acidosomes (late endosomes) in Paramecium.

Masaaki Iwamoto1, Richard D Allen.   

Abstract

The ciliated protozoan Paramecium incorporates sphingolipids into its cell membranes. However, it is still unclear if these sphingolipids are metabolically synthesized in the cell or if their precursors are taken up from exogenous materials. Here we studied the route of uptake of fluorescence-labeled analogues of ceramide. Fluorescent ceramide was taken up rapidly independent of phagosome formation. Cold treatment caused a decrease in uptake, while reduction in the amount of cytosolic ATP induced by NaN(3) and deoxyglucose resulted in accumulation without internalization of fluorescence at the plasma membrane. These results suggest that uptake of fluorescent ceramide occurs at the plasma membrane, that it is an ATP-dependent process, and that it is not a result of simple diffusion. At first intracellular fluorescence appeared principally in the posterior half of the cell and then spread throughout the cytosol. In particular, a high accumulation of fluorescence occurred in association with acidosomes (late endosome or multivesicular body-like vesicles) that bind to the surface of nascent and young phagosomes. Therefore, in the Paramecium cell a significant proportion of ceramide apparently enters the cell by endocytosis and is quickly relayed to acidosomes along the endocytic pathway before becoming part of the digestive vacuole (phagoacidosome) membrane.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100234     DOI: 10.1177/002215540405200501

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  3 in total

1.  Identification of contractile vacuole proteins in Trypanosoma cruzi.

Authors:  Paul N Ulrich; Veronica Jimenez; Miyoung Park; Vicente P Martins; James Atwood; Kristen Moles; Dalis Collins; Peter Rohloff; Rick Tarleton; Silvia N J Moreno; Ron Orlando; Roberto Docampo
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

2.  Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment.

Authors:  María José Godoy-Calderón; Eglys González-Marcano; Jeismar Carballo; Ana Federica Convit
Journal:  Oncotarget       Date:  2019-11-12

3.  Autologous tumor cells/bacillus Calmette-Guérin/formalin-based novel breast cancer vaccine induces an immune antitumor response.

Authors:  María José Godoy-Calderón; Víctor Salazar; Eglys González-Marcano; Ana Federica Convit
Journal:  Oncotarget       Date:  2018-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.